Table 3 Summary of cost-effectiveness analysis results
From: Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
Probabilistic results | Carbetocin | Oxytocin |
|---|---|---|
Cesarean section (CS) | ||
 Total costs | 555 | 542 |
 Total QALYs | 0.82797 | 0.82697 |
 Incremental cost |  | 13.19 |
 Incremental QALY |  | 0.001000 |
 ICER per QALY gained (USD/QALY gained) |  | 13,187 |
Vaginal delivery (VD) | ||
 Total cost | 292 | 274 |
 Total QALY | 0.84535 | 0.84494 |
 Incremental cost |  | 17.49 |
 Incremental QALY |  | 0.000405 |
 ICER per QALY gained (USD/QALY gained) |  | 43,164 |